Subcutaneous Drug Delivery Devices Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Subcutaneous Drug Delivery Devices Market, By Product

7.1.  Subcutaneous Drug Delivery Devices Market, by Product Type, 2020-2030

7.1.1.    Prefilled syringes

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Pen injectors

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Autoinjectors

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Wearable injectors

7.1.4.1.        Market Revenue and Forecast (2016-2030)

7.1.5.    Needle-free injectors

7.1.5.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Subcutaneous Drug Delivery Devices Market, By Distribution Channel

8.1.  Subcutaneous Drug Delivery Devices Market, By Distribution Channel, 2020-2030

8.1.1.    Hospital pharmacies

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Retail pharmacies

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Online pharmacies

8.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Subcutaneous Drug Delivery Devices Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Product (2016-2030)

9.1.2.    Market Revenue and Forecast, By Distribution Channel (2016-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Product (2016-2030)

9.1.3.2.        Market Revenue and Forecast, By Distribution Channel (2016-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Product (2016-2030)

9.1.4.2.        Market Revenue and Forecast, By Distribution Channel (2016-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Product (2016-2030)

9.2.2.    Market Revenue and Forecast, By Distribution Channel (2016-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Product (2016-2030)

9.2.3.2.        Market Revenue and Forecast, By Distribution Channel (2016-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Product (2016-2030)

9.2.4.2.        Market Revenue and Forecast, By Distribution Channel (2016-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Product (2016-2030)

9.2.5.2.        Market Revenue and Forecast, By Distribution Channel (2016-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Product (2016-2030)

9.2.6.2.        Market Revenue and Forecast, By Distribution Channel (2016-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Product (2016-2030)

9.3.2.    Market Revenue and Forecast, By Distribution Channel (2016-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Product (2016-2030)

9.3.3.2.        Market Revenue and Forecast, By Distribution Channel (2016-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Product (2016-2030)

9.3.4.2.        Market Revenue and Forecast, By Distribution Channel (2016-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Product (2016-2030)

9.3.5.2.        Market Revenue and Forecast, By Distribution Channel (2016-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Product (2016-2030)

9.3.6.2.        Market Revenue and Forecast, By Distribution Channel (2016-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Product (2016-2030)

9.4.2.    Market Revenue and Forecast, By Distribution Channel (2016-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Product (2016-2030)

9.4.3.2.        Market Revenue and Forecast, By Distribution Channel (2016-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Product (2016-2030)

9.4.4.2.        Market Revenue and Forecast, By Distribution Channel (2016-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Product (2016-2030)

9.4.5.2.        Market Revenue and Forecast, By Distribution Channel (2016-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Product (2016-2030)

9.4.6.2.        Market Revenue and Forecast, By Distribution Channel (2016-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Product (2016-2030)

9.5.2.    Market Revenue and Forecast, By Distribution Channel (2016-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Product (2016-2030)

9.5.3.2.        Market Revenue and Forecast, By Distribution Channel (2016-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Product (2016-2030)

9.5.4.2.        Market Revenue and Forecast, By Distribution Channel (2016-2030)

Chapter 10.  Company Profiles

10.1.              Gerresheimer AG

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Medtronic Plc

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Ypsomed AG

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Elcam Medical Group

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Novo Nordisk

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Insulet Corporation

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Becton, Dickinson and Company

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              West Pharmaceutical Services, Inc.

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              PharmaJet

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           Unilife Corporation

10.10.1.               Company Overview

10.10.2.               Product Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

10.11.           Inolife Sciences

10.11.1.               Company Overview

10.11.2.               Product Offerings

10.11.3.               Financial Performance

10.11.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms